Open-label study to evaluate the pharmacokinetics of fidaxomicin in inflammatory bowel disease patients with Clostridium difficile infection (the PROFILE study): pharmacokinetics analysis - Hoegenauer, C; Mahida, Y; Stallmach, A (Journal of Crohn's and Colitis, 2017)